Percheron Therapeutics (ASX:PER) - Key People
ASX:PER · Directors, executives and key personnel · 12 month lookback
Dr James Garner
Current
Chief Executive Officer and Managing Director
Mentioned in
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Percheron Therapeutics Launches Vanderbilt-Led Trial for HMBD-002 in AML
28 Aug 2026
Healthcare Wrap - Week 34 (17 Aug -> 21 Aug) 2026
22 Aug 2026
Percheron Therapeutics narrows FY2026 loss, advances HMBD-002 oncology drug with phase II trial planned
19 Aug 2026
Also Mentioned
People named in Percheron Therapeutics (ASX:PER) articles over the last 12 months, by frequency.
Charmaine Gittleson
· 9 articles
Michael Baker
· 5 articles
Ben Gil Price
· 4 articles
Somedeb Ball
· 2 articles
Deborah Ambrosini
· 2 articles
Professor Sudha R
· 1 article
Eugene Kennedy
· 1 article
Valentina Dubljevic
· 1 article